Table 2 Multivariate Cox regression analysis of overall survival for American patients

From: Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors

  

Overall survival

Characteristic

No.

HR

95% CI

P- value a

Age

Gender

55

1.051

1.030–1.133

0.007

Female

24

   

Male

31

0.746

0.266–2.094

0.577

pT Stage

T1

8

1

 

0.224

T2

26

1.856

0.297–11.596

0.508

T3

16

0.664

0.097–4.556

0.677

T4

5

3.693

0.325–1.981

0.292

pN Stage

N0 (reference)

15

1

  

N1

22

8.912

1.644–48.309

0.011

N2

12

25.629

3.853–120.468

0.001

N3

3

283.533

13.988–4965.867

0.000

Gal-3 expression

0⩽3.5 (reference)

26

1

  

1⩾3.5

29

4.886

1.898–12.577

0.001

  1. Abbreviations: CI=confidence interval; HR=hazard ratio.
  2. aP calculated by using Log-rank test.
Back to article page